SALIX PHARMACEUTICALS LTD Proceeds from Stock Options Exercised
SALIX PHARMACEUTICALS LTD reported Proceeds from Stock Options Exercised of $7.12 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-02.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2015-03-02
- SALIX PHARMACEUTICALS LTD proceeds from stock options exercised for the quarter ending 2014-12-31 was $1.55M, a 107.37% increase year-over-year.
- SALIX PHARMACEUTICALS LTD proceeds from stock options exercised for the quarter ending 2014-09-30 was $2.08M, a 259.24% increase year-over-year.
- SALIX PHARMACEUTICALS LTD proceeds from stock options exercised for the quarter ending 2014-06-30 was $1.13M, a 47.36% decline year-over-year.
- SALIX PHARMACEUTICALS LTD proceeds from stock options exercised for the quarter ending 2014-03-31 was $2.37M, a 213.10% increase year-over-year.
- SALIX PHARMACEUTICALS LTD proceeds from stock options exercised for fiscal 2014 was $7.12M, a 68.78% increase from fiscal 2013.
- SALIX PHARMACEUTICALS LTD proceeds from stock options exercised for fiscal 2013 was $4.22M, a 50.56% decline from fiscal 2012.
- SALIX PHARMACEUTICALS LTD proceeds from stock options exercised for fiscal 2012 was $8.53M, a 58.12% increase from fiscal 2011.
- SALIX PHARMACEUTICALS LTD proceeds from stock options exercised for fiscal 2011 was $5.40M.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2014-12-31 | $1.55M derived: 10-K 12 month − 10-Q/A 9 month · filed 2015-03-02 | $3.63M derived: sum of 2 quarters · filed 2015-03-02 | $4.75M derived: sum of 3 quarters · filed 2015-03-02 | $7.12M 10-K · filed 2015-03-02 |
| 2014-09-30 | $2.08M derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2015-03-02 | $3.21M derived: sum of 2 quarters · filed 2015-03-02 | $5.57M 10-Q/A · filed 2015-03-02 | $6.32M derived: sum of 4 quarters · filed 2015-03-02 |
| 2014-06-30 | $1.13M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2015-03-02 | $3.49M 10-Q/A · filed 2015-03-02 | $4.24M derived: sum of 3 quarters · filed 2015-03-02 | $4.82M derived: sum of 4 quarters · filed 2015-03-02 |
| 2014-03-31 | $2.37M 10-Q/A · filed 2015-03-02 | $3.11M derived: sum of 2 quarters · filed 2015-03-02 | $3.69M derived: sum of 3 quarters · filed 2015-03-02 | $5.83M derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-12-31 | $746.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2015-03-02 | $1.32M derived: sum of 2 quarters · filed 2015-03-02 | $3.46M derived: sum of 3 quarters · filed 2015-03-02 | $4.22M 10-K · filed 2015-03-02 |
| 2013-09-30 | $579.00K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2015-03-02 | $2.72M derived: sum of 2 quarters · filed 2015-03-02 | $3.47M 10-Q/A · filed 2015-03-02 | |
| 2013-06-30 | $2.14M derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2015-03-02 | $2.89M 10-Q/A · filed 2015-03-02 | ||
| 2013-03-31 | $756.00K 10-Q/A · filed 2015-03-02 | |||
| 2012-12-31 | $8.53M 10-K · filed 2015-03-02 | |||
| 2011-12-31 | $5.40M 10-K · filed 2015-03-02 |